Women deserve world-class support at every stage—from family building to menopause
As employers increasingly recognize that women navigate healthcare not only for themselves but as the primary decision-makers for entire families, Transcarent has expanded its integrated platform to include five specialized women's health providers—Maven Clinic, Midi Health, Progyny, Carrot, and Kindbody—offering unified access to fertility, pregnancy, and menopause care across a network of more than 20 million people. The move reflects a quiet but meaningful reckoning in corporate benefits: that fragmented, underutilized health solutions are both a financial inefficiency and a human failure. By consolidating what was once a maze of separate contracts and disconnected services into a single navigable system, the platform asks whether simplicity itself might be a form of care.
- Women's health benefits have long been scattered across disconnected vendors, leaving employees confused and employers paying for services that go largely unused.
- The addition of Maven Clinic, Midi Health, and Progyny to an existing roster of Carrot and Kindbody creates sudden pressure on competitors to match a five-partner, full-lifecycle offering.
- Transcarent's AI navigation tool is generating 7.6 times more referrals to women's health services, signaling that the bottleneck was never supply—it was findability.
- Midlife and menopause care, historically underfunded relative to fertility services, is being repositioned as a strategic employer priority rather than an afterthought.
- With 1,700-plus employers already on the platform, the five partners gain immediate access to a massive pre-qualified market without the friction of individual sales cycles.
- The platform is landing as a consolidation play that promises employers both operational simplicity and measurable utilization gains of 10 to 20 percent.
Transcarent, a health platform reaching more than 20 million people across 1,700 employers and health plans, announced the addition of three women's health providers—Maven Clinic, Midi Health, and Progyny—to its integrated system. They join existing partners Carrot and Kindbody, forming a five-provider marketplace where employers can offer workers access to fertility, pregnancy, parenting, and menopause care through a single platform, without negotiating separate contracts with each vendor.
The expansion reflects a broader shift in how employers approach women's health. Women tend to make healthcare decisions not just for themselves but for their families, and their needs change substantially across life stages. Transcarent's Experience Store consolidates specialized providers into one sign-on system with unified reporting and outcomes tracking—an attempt to replace fragmentation with coherence. Company president Snezana Mahon framed it as women deserving world-class support at every stage of life.
Each partner addresses a distinct gap. Maven Clinic offers round-the-clock virtual care spanning fertility through menopause. Midi Health focuses on perimenopause and menopause, conditions that have historically received far less clinical investment than fertility services. Progyny pairs comprehensive family-building support with dedicated care advocates. The announcement was timed to Menopause Awareness Month, a deliberate signal that midlife women's health is being elevated, not treated as secondary.
The financial case for employers is concrete. Transcarent's AI-powered WayFinding tool drives 7.6 times more referrals to women's health solutions compared to baseline, and the platform claims to reduce care fragmentation by 10 to 20 percent—meaning more employees actually use what's available to them. For the partner companies, the arrangement offers access to a large, pre-qualified employer base without the burden of individual sales cycles. Transcarent vets all partners for clinical quality, security, and operational stability before integration, giving employers confidence in the providers they're offering their workforces.
Transcarent, a health platform serving more than 20 million people across 1,700 employers and health plans, announced on Tuesday that it has brought three major women's health providers into its integrated system: Maven Clinic, Midi Health, and Progyny. These join two existing partners, Carrot and Kindbody, creating what the company describes as a unified marketplace where employers can offer their workers access to comprehensive care spanning fertility, pregnancy, parenting, and menopause—all without having to negotiate separate contracts with each provider.
The move reflects a broader shift in how employers think about women's health benefits. Women typically make healthcare decisions not just for themselves but for their entire families, and their medical needs shift substantially across different life stages. Transcarent's platform, called the Experience Store, attempts to simplify this complexity by consolidating multiple specialized providers into a single sign-on system with unified reporting and measurable outcomes tracking. The company's president, Snezana Mahon, framed the expansion as a response to women deserving "world-class support at every stage—from family building to menopause."
Each partner brings distinct expertise. Maven Clinic operates what it calls the world's largest virtual clinic for women and families, offering services from fertility planning through menopause care, with access to clinicians around the clock. Midi Health focuses specifically on perimenopause and menopause, conditions that have historically received less clinical attention and investment than fertility services. Progyny provides comprehensive family-building support paired with dedicated care advocates who guide members through their journeys. Carrot and Kindbody, the existing partners, round out the offering with fertility and family-building expertise.
The financial incentive for employers is substantial. Transcarent's data shows that when employers use its AI-powered navigation tool, called WayFinding, referrals to women's health solutions increase 7.6 times compared to baseline. The platform also claims to reduce fragmentation in care by 10 to 20 percent, meaning more employees actually use the services available to them. For employers managing healthcare costs while trying to attract and retain talent, particularly women, the consolidated approach offers both operational simplicity and measurable utilization gains.
The timing of the announcement—during October, designated as Menopause Awareness Month—underscores a deliberate effort to elevate midlife women's health, a category that has historically been underfunded relative to fertility services. Joanna Strober, CEO of Midi Health, noted that "midlife women have been underserved for far too long," and the partnership allows her company to reach women "where they are" with expert care grounded in clinical best practices.
For the five partner companies, the arrangement offers access to a large, pre-qualified employer base without the burden of individual sales and contracting cycles. Maven's CEO, Kate Ryder, emphasized that the partnership allows her company to meet "women and families when they need us most" while simultaneously reducing costs for employers. Pete Anevski of Progyny highlighted how combining his company's clinical model with Transcarent's platform infrastructure could expand access to expert support and improve outcomes at scale.
Transcarent vets all partners for clinical quality, security, financial stability, and operational excellence before integration, a gatekeeping function that gives employers confidence they are not exposing their workforce to untested or unstable providers. The company currently serves employers and health plans across multiple care categories—mental health, diabetes, musculoskeletal care, and others—through its Experience Store model. Women's health now represents a major vertical within that ecosystem, reflecting both the size of the addressable market and the strategic importance employers place on reproductive and midlife health benefits.
Citas Notables
Women are the chief health officers of their households, and they deserve world-class support at every stage—from family building to menopause.— Snezana Mahon, President of Transcarent
Midlife women have been underserved for far too long. By joining the Transcarent Experience Store, we're meeting women where they are with expert menopause and perimenopause care.— Joanna Strober, CEO & Co-founder of Midi Health
La Conversación del Hearth Otra perspectiva de la historia
Why does consolidating these five providers into one platform matter more than just having them available separately?
Because most people don't know these services exist, and even if they do, they have to navigate five different sign-ons, five different eligibility processes, five different user experiences. Transcarent's data shows that when you put them all in one place with smart navigation, referrals go up 7.6 times. That's not marketing—that's friction removal.
But couldn't an employer just contract with all five separately?
Technically yes, but then they're managing five different vendors, five different reporting systems, five different billing relationships. Transcarent handles the integration, the unified reporting, the outcome tracking. It's the difference between buying five separate tools and buying one integrated system.
What's the actual clinical difference between these providers? Why does an employer need all five?
They serve different moments in a woman's life and different clinical needs. Maven covers the full spectrum from preconception through menopause. Midi specializes in perimenopause and menopause specifically—conditions that have been neglected for decades. Progyny focuses on family building with dedicated advocates. Carrot and Kindbody fill gaps in fertility and family care. An employer offering all five can say to their workforce: we have expert support for whatever stage you're in.
Is this really about clinical excellence or about market consolidation?
Both. Transcarent is consolidating the vendor landscape to make it easier for employers to buy. But the underlying reason employers want this is real—women's health benefits are becoming a competitive advantage in hiring and retention. The clinical excellence matters because employers are now measuring outcomes, not just offering access.
What happens to the smaller women's health startups that aren't part of this?
They either get acquired, integrate into platforms like this one, or stay independent and compete on clinical differentiation. Transcarent's vetting process—clinical quality, security, financial stability—creates a high bar. If you can't meet it, you're out. That's consolidation pressure, but it's also a signal about which companies are likely to survive.